BioSpace News Archive

Some useful tips to face and conquer the first day

Starting a New Job? How to Overcome the First-Day New Job Jitters

Being the “new kid in class” is always a little nerve-wracking, whether you’re 13 or 45. Here are some useful tips to help you face the new job jitters in the best way.

April 17, 2018

·

3 min read

3d illustration of a cancer cell and lymphocytes

Pharm Country

General Electric Creates Ready-Made Viral Drug Factories for Pharma and Biotech Companies

General Electric is diving deeper into the world of biotechnology. The conglomeration is launching prefabricated manufacturing units to product virus-based gene and cell therapies, Reuters reported this morning.

April 17, 2018

·

2 min read

·

Alex Keown

Network Technology Cooperation and Transaction

Business

Kineta Chronic Pain Inks License Deal with Genentech for Over $359 Million

Kineta Chronic Pain signed an exclusive option and license deal with Genentech. The two companies will develop Kineta’s alpha9/alpha10 nicotinic acetylcholine receptor (nAChR) antagonists to treat chronic pain.

April 17, 2018

·

2 min read

·

Mark Terry

Deals

Sanofi to Sell its Generic Division to Advent for $2.4 Billion

Sanofi has agreed to sell its generics division, Zentiva, to Advent International. The deal is expected to wrap by the end of this year.

April 17, 2018

·

2 min read

·

Mark Terry

J&J Terminates RA and Leukemia Drug From Pipeline

Drug Development

Pharma Sales Drive J&J’s First Quarter

Johnson & Johnson reported a strong first quarter with $20 billion in sales that was fueled by significant growth in its pharmaceuticals business.

April 17, 2018

·

2 min read

·

Alex Keown

Drug Development

FDA Grants Genentech’s Hemophilia Drug Breakthrough Therapy Designation Despite Reports of Patient Deaths

The U.S. Food and Drug Administration (FDA) granted Genentech, a Roche company, Breakthrough Therapy Designation for Hemlibra (emicizumab-kxwh) for hemophilia A without factor VIII inhibitors.

April 17, 2018

·

3 min read

·

Mark Terry

Drug Development

AACR Meeting Brief: H3 Biomedicine, Checkmate, Deciphera and More

The following is a roundup of presentations and findings from multiple companies participating in the 2018 American Association for Cancer Research (AACR) in Chicago.

April 17, 2018

·

3 min read

·

Alex Keown

Drug Development

Novartis to Spend $100M on Malaria Initiative

Mosquito-borne illnesses are a major concern in many parts of the world. One of the nastier viruses carried by mosquitoes, malaria, was responsible for the deaths of more than 445,000 people in 2016. One biotech is aiming to make a difference.

April 17, 2018

·

2 min read

·

Alex Keown

Drug Development

AACR Meeting Brief: Compugen, Bayer, Tarveda, Alligator and Others

Now in its fourth day, the American Association of Cancer Research (AACR) Annual Meeting 2018 held in Chicago, has had plenty of news, much of it preclinical or early-clinical data.

April 17, 2018

·

3 min read

·

Mark Terry

Business

Janssen, Bristol-Myers Squibb Team Up to Develop Therapy

Janssen Pharmaceuticals has teamed up with Bristol-Myers Squibb to drive BMS-986177, a Factor XIa (FXIa) inhibitor, into Phase II development for the study of secondary stroke prevention and major thrombotic conditions.

April 17, 2018

·

3 min read

·

Alex Keown